Nature News reports today on three different studies that successfully used stem cell therapies to sprout new hair on bald mice, restore some vision to night-blind mice, and improve the heart function of mice with a cardiac injury. All three methods could eventually be adapted for use in humans.
Robert Lanza, Chief Scientific Officer at Advanced Cell Technologies, a regenerative medicine biotechnology company, told Nature:
“By the time we grow old, doctors are going to look back and say, ‘Can you believe people used to go bald, go blind or even have their leg cut off from vascular disease?’ —then [they] will treat the problem with an injection of [stem] cells.”
In January Lanza’s company reported that embryonic stem cells could be safely injected into the eyes of human patients suffering deteriorating vision, although the efficacy of the treatment is unknown.
Five poems about the mind
Work reinvented: Tech will drive the office evolution
As organizations navigate a new world of hybrid work, tech innovation will be crucial for employee connection and collaboration.
Investing in people is key to successful transformation
People-related factors like talent attraction and retention and clear top-down communication will determine whether your transformation progresses or stalls.
Be a good example
"It was in the newspaper, but the towers fell the next day, and what I’d done was quickly lost."
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.